1. NF-κB
  2. NF-κB
  3. mcIRBP-9

mcIRBP-9 is an orally bioavailable NF-κB inhibitor. mcIRBP-9 reduces the levels of TNF-α, IL-1β and TGF-β1 in renal tissues, and decreases LPS-induced IL-1β production. mcIRBP-9 can be used in research related to diabetic nephropathy and type 2 diabetes mellitus.

For research use only. We do not sell to patients.

Custom Peptide Synthesis

mcIRBP-9

mcIRBP-9 Chemical Structure

CAS No. : 1489241-80-6

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products

View All NF-κB Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

mcIRBP-9 is an orally bioavailable NF-κB inhibitor. mcIRBP-9 reduces the levels of TNF-α, IL-1β and TGF-β1 in renal tissues, and decreases LPS-induced IL-1β production. mcIRBP-9 can be used in research related to diabetic nephropathy and type 2 diabetes mellitus[1].

In Vivo

mcIRBP-9 (1-10 μmol kg−1; p.o.; once daily or single dose; 12 consecutive weeks or short-term) improves glucose clearance in a dose-dependent manner, reduces long-term blood glucose and HbA1c levels, improves survival rate to 100%, and ameliorates diabetic nephropathy in db/db mice via anti-inflammatory and reno-protective effects[1].
mcIRBP-9 (1 μmol kg−1; p.o.; single dose given after LPS challenge) suppresses LPS-induced renal NF-κB activity and systemic IL-1β production in NF-κB transgenic mice, demonstrating anti-inflammatory activity relevant to nephropathy[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: NF-κB transgenic (male, 6-week-old)[1]
Dosage: 1 μmol kg-1
Administration: p.o.; single dose given after LPS challenge
Result: Reduced serum IL-1β levels by 69.28 % compared to LPS-only controls.
Suppressed LPS-induced renal NF-κB-dependent luminescent intensities by 61.78 % compared to LPS-only controls.
Molecular Weight

923.11

Formula

C42H74N12O11

CAS No.
Sequence

Ile-Val-Ala-Arg-Pro-Pro-Thr-Ile-Gly

Sequence Shortening

IVARPPTIG

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
mcIRBP-9
Cat. No.:
HY-P11736
Quantity:
MCE Japan Authorized Agent: